Research output per year
Research output per year
Search results
-
2024
Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma
Waked, A., Crabbé, M., Neirinckx, V., Pérez, S. R., Wellens, J., Rogister, B., Benotmane, M. A. & Vermeulen, K., Dec 2024, In: EJNMMI Radiopharmacy and Chemistry. 9, 1, 23 p., 52.Research output › peer-review
Open AccessFile10 Downloads (Pure) -
Targeted radiopharmaceuticals: an underexplored strategy for ovarian cancer
Crabbé, M., Opsomer, T., Vermeulen, K., Ooms, M. & Segers, C., 2024, In: Theranostics. 14, 16, p. 6281-6300 20 p.Research output › peer-review
Open Access -
The dose-reponse effects of the additional Auger and IC electrons of 161Tb- compared to 177Lu- labelled agonists and antagonists
Spoormans, K., Struelens, L., Vermeulen, K., De Saint-Hubert, M., Koole, M. & Crabbé, M., 2024, EANM’24 Abstract Book. 2024 ed. EANM - European Association of Nuclear Medicine, 1 p. OP-023Research output › peer-review
Open AccessFile36 Downloads (Pure) -
The emission of internal conversion electrons rather than auger electrons increased the Nucleus-absorbed dose for 161Tb compared with 177Lu with a higher dose response for [161Tb]Tb-DOTA-LM3 than for [161Tb]Tb-DOTATATE
Spoormans, K., Struelens, L., Vermeulen, K., De Saint-Hubert, M., Koole, M. & Crabbé, M., 1 Oct 2024, In: Journal of Nuclear Medicine. 65, 10, p. 1619-1625 7 p., 267873.Research output › peer-review
Open Access -
2022
A Review on Tumor Control Probability (TCP) and Preclinical Dosimetry in Targeted Radionuclide Therapy (TRT)
Spoormans, K., Crabbé, M., Struelens, L., De Saint-Hubert, M. & Koole, M., 22 Sep 2022, In: Pharmaceutics. 14, 10, 19 p., 2007.Research output › peer-review
Open Access -
Exploring the potential of high-molar activity Samarium-153 for targeted radionuclide therapy with [153Sm]Sm-DOTA-TATE
Vermeulen, K., Van de Voorde, M., Segers, C., Coolkens, A., Rodriguez Perez, S., Duchemin, C., Crabbé, M., Opsomer, T., Saldarriaga Vargas, C., Reinhard, H., Lambert, L., Bernerd, C., Burgoyne, A., Cocolios, T. E., Stora, T. & Ooms, M., 18 Nov 2022, In: Pharmaceutics. 14, p. 1-15 15 p., 2566.Research output › peer-review
Open Access -
O-27 - Using high-specific activity Samarium-153 for the development of [153Sm] Sm DOTA-TATE for targeted radionuclide therapy of neuroendocrine tumors
Vermeulen, K., Van de Voorde, M., Daems, N., Duchemin, C., Rodriguez Pérez, S., Crabbé, M., Reinhard, H., Ponsard, B., Geenen, L., Nonnekens, J., Lambert, L., Bernerd, C., Burgoyne, A., Cocolios, T. E., Stora, T. & Ooms, M., May 2022, In: Nuclear Medicine and Biology. 108-109, Supplement, p. S20 1 p.Research output › peer-review
Open Access -
2021
Review of extremity dosimetry in nuclear medicine
Kollaard, R. P., Zorz, A., Dabin, J., Covens, P., Cooke, J., Crabbé, M., Cunha, L., Dowling, A., Ginjaume, M. & McNamara, L., 6 Dec 2021, In: Journal of Radiological protection. 41, p. 1-29 29 p., R60.Research output › peer-review
Open Access -
2020
Targeted alpha therapy: a critical review of translational dosimetry research with emphasis on actinium-225
Castillo, D., De Saint-Hubert, M., Crabbé, M., Struelens, L. & Koole, M., 15 May 2020, (E-pub ahead of print) In: The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 64, p. 1-13 13 p.Research output › peer-review
Open Access